| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0378-5173(01)00678-0 |
| P698 | PubMed publication ID | 11397578 |
| P2093 | author name string | B Z Chowdhry | |
| T Riley | |||
| M J Snowden | |||
| C J Davies-Cutting | |||
| I C Ashurst | |||
| Y Michael | |||
| P2860 | cites work | Effect of shear schedule on particle size, density, and structure during flocculation in stirred tanks | Q60484270 |
| The effect of surfactant and solid phase concentration on drug aggregates in model aerosol propellent suspensions | Q71507192 | ||
| Rheology of model aerosol suspensions | Q72234739 | ||
| The physico-chemical properties of salmeterol and fluticasone propionate in different solvent environments | Q73924851 | ||
| Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers | Q77321212 | ||
| Surfactant dissolution and water solubilization in chlorine-free liquified gas propellants | Q77756529 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fluticasone propionate | Q8564098 |
| P304 | page(s) | 165-174 | |
| P577 | publication date | 2001-06-01 | |
| P1433 | published in | International Journal of Pharmaceutics | Q6051539 |
| P1476 | title | Characterisation of the aggregation behaviour in a salmeterol and fluticasone propionate inhalation aerosol system | |
| P478 | volume | 221 |
| Q30476221 | Determination of reference ultrasound parameters for model and hydrofluoroalkane propellants using high-resolution ultrasonic spectroscopy |
| Q34266098 | Development of a sensitive method for simultaneous determination of fluticasone propionate and salmeterol in plasma samples by liquid chromatography-tandem mass spectrometry |
| Q43270442 | Engineering of crystalline combination inhalation particles of a long-acting beta2-agonist and a corticosteroid |
| Q39135769 | Fluticasone uptake across Calu-3 cells is mediated by salmeterol when deposited as a combination powder inhaler |
| Q51104794 | In vitro investigation of drug particulates interactions and aerosol performance of pressurised metered dose inhalers. |
| Q33338521 | Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystals |
| Q40374524 | Lorentz contact resonance spectroscopy for nanoscale characterisation of structural and mechanical properties of biological, dental and pharmaceutical materials |
| Q37937562 | Novel cosuspension metered-dose inhalers for the combination therapy of chronic obstructive pulmonary disease and asthma |
| Q36316856 | Novel hydrofluoroalkane suspension formulations for respiratory drug delivery |
| Q36316663 | Propellant-driven metered-dose inhalers for pulmonary drug delivery |
| Q38065263 | Pulmonary dispersion formulations: the impact of dispersed powder properties on pressurized metered dose inhaler stability |
| Q33215447 | Surface energy and interparticle forces correlations in model pMDI formulations |
| Q58261139 | The Use of AFM and Surface Energy Measurements to Investigate Drug-Canister Material Interactions in a Model Pressurized Metered Dose Inhaler Formulation |
| Q43266617 | The influence of flow rate on the aerosol deposition profile and electrostatic charge of single and combination metered dose inhalers |
| Q35169751 | The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers. |
| Q39382225 | Variability in Delivered Dose from Pressurized Metered-Dose Inhaler Formulations Due to a Delay Between Shake and Fire |
Search more.